Back to Point72 Asset Management, L.P. Point72 Asset Management, L.P.

HAHAE
27 quarters

Position history for Point72 Asset Management, L.P.Point72 Asset Management, L.P.'s holdings in HAEMONETICS CORP MASS

Point72 Asset Management, L.P. holds 109,236 shares of HAE (HAEMONETICS CORP MASS), worth $8.2M as of 2026-Q2. The position was increased (+92.1% shares). HAE represents 0.0% of Point72 Asset Management, L.P.'s portfolio.

Current Value

$8.2M

Current Shares

109,236

Total Value Change

-$72.2M

Total Shares Change

-694,526

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
109,236
+92.1%
$8.2M0.0%$75.00
43
2026-Q1
Decreased
56,868
-93.3%
$3.2M0.0%$65.63
0
2025-Q4
Increased
853,379
+1882.3%
$68.4M0.1%$80.98
48
2025-Q3
Decreased
43,051
-90.2%
$2.1M0.0%$48.12
0
2025-Q2
Increased
438,324
+4.1%
$32.7M0.1%$73.80
30
2025-Q1
New
420,930
-
$26.8M0.1%$63.19
40
2024-Q3
Exited
0
-100.0%
$00.0%$79.80
0
2024-Q2
Increased
219,024
+178.3%
$18.1M0.0%$82.73
46
2024-Q1
Decreased
78,700
-8.6%
$6.7M0.0%$85.35
0
2023-Q4
New
86,083
-
$7.4M0.0%$85.51
38
2023-Q2
Exited
0
-100.0%
$00.0%$84.84
0
2023-Q1
Decreased
29,700
-92.1%
$2.5M0.0%$80.17
0
2022-Q4
Decreased
373,846
-33.0%
$29.4M0.1%$78.65
0
2022-Q3
Increased
557,539
+36.4%
$41.3M0.2%$73.61
45
2022-Q2
New
408,897
-
$26.7M0.1%$65.97
47
2021-Q4
Exited
0
-100.0%
$00.0%$53.56
0
2021-Q3
Increased
266,100
+193.7%
$18.8M0.1%$70.46
46
2021-Q2
Decreased
90,600
-52.2%
$6M0.0%$66.73
0
2021-Q1
Decreased
189,700
-32.4%
$21.1M0.1%$112.37
0
2020-Q4
Decreased
280,432
-83.2%
$33.3M0.2%$118.92
0
2020-Q3
Increased
1.7M
+104.0%
$145.4M0.7%$86.86
69
2020-Q2
Increased
816,825
+79.4%
$73.2M0.5%$87.99
54
2020-Q1
New
455,383
-
$45.4M0.4%$101.93
48
2019-Q3
Exited
0
-100.0%
$00.0%$124.18
0
2019-Q2
Decreased
339,961
-60.4%
$40.9M0.2%$120.34
0
2019-Q1
Increased
859,410
+6.9%
$75.2M0.3%$87.48
38
2018-Q4
New
803,762
-
$80.4M0.4%$95.73
49

Other major holders of HAE: Capital Research Global Investors, BNP PARIBAS FINANCIAL MARKETS

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used